Company · CIK 1699382

# PMV Pharmaceuticals, Inc.

| CIK | [1699382](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001699382) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | NJ |
| Listed | PMVP (Nasdaq) |
| First annual or quarterly report | 2020-11-13 |

## Offerings

 3 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-283349 | Shelf Effective | 2024-11-20 | 2026-09-02 | 4 |
| 333-260012 | Shelf Effective | 2021-10-04 | 2023-04-28 | 2 |
| 333-248627 | IPO Final prospectus | 2020-09-04 | 2020-09-25 | 5 |

## Filings

 12

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-09-02 | [424B5](https://www.sec.gov/Archives/edgar/data/1699382/000119312526378780/0001193125-26-378780-index.htm) Shelf takedown | 333-283349 | 0001193125-26-378780 |
| 2026-08-31 | [424B5](https://www.sec.gov/Archives/edgar/data/1699382/000119312526376860/0001193125-26-376860-index.htm) Shelf takedown | 333-283349 | 0001193125-26-376860 |
| 2024-11-27 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1699382/999999999524003606/9999999995-24-003606-index.htm) Declared effective | 333-283349 | 9999999995-24-003606 |
| 2024-11-20 | [S-3](https://www.sec.gov/Archives/edgar/data/1699382/000119312524262148/0001193125-24-262148-index.htm) Shelf registered | 333-283349 | 0001193125-24-262148 |
| 2023-04-28 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1699382/999999999523001090/9999999995-23-001090-index.htm) Declared effective | 333-260012 | 9999999995-23-001090 |
| 2021-10-04 | [S-3ASR](https://www.sec.gov/Archives/edgar/data/1699382/000119312521290972/0001193125-21-290972-index.htm) Shelf registered | 333-260012 | 0001193125-21-290972 |
| 2020-09-25 | [424B4](https://www.sec.gov/Archives/edgar/data/1699382/000119312520254551/0001193125-20-254551-index.htm) Final prospectus | 333-248627 | 0001193125-20-254551 |
| 2020-09-24 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1699382/999999999520002572/9999999995-20-002572-index.htm) Declared effective | 333-248627 | 9999999995-20-002572 |
| 2020-09-24 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1699382/000119312520252783/0001193125-20-252783-index.htm) Amendment | 333-248627 | 0001193125-20-252783 |
| 2020-09-21 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1699382/000119312520249570/0001193125-20-249570-index.htm) Amendment | 333-248627 | 0001193125-20-249570 |
| 2020-09-04 | [S-1](https://www.sec.gov/Archives/edgar/data/1699382/000119312520240132/0001193125-20-240132-index.htm) Registration filed | 333-248627 | 0001193125-20-240132 |
| 2020-06-26 | [DRS](https://www.sec.gov/Archives/edgar/data/1699382/000095012320006405/0000950123-20-006405-index.htm) Draft made public | 377-03247 | 0000950123-20-006405 |

[All filings of this company](https://equitycapital.markets/filings?cik=1699382) · [CSV](https://equitycapital.markets/filings.csv?cik=1699382)

---
Source page: https://equitycapital.markets/company/1699382 · Data: U.S. SEC EDGAR · CC BY 4.0